Eble JN, Sauter G., Epstein JI, Sesterhenn IA - iarc

1093. Hill MJ (1979). Role of bacteria in
human carcinogenesis. J Hum Nutr 33: 416-
426.
1094. Hilton S (2000). Imaging of renal cell
carcinoma. Semin Oncol 27: 150-159.
1095. Hinman F, Gibson T.E. (1924). Tumors
of the epididymis, spermatic cord and testicular
tunics. A review of the literature and
a report of three new cases. Arch Surg 8:
100-137.
1096. Hiratsuka Y, Nishimura H, Kajiwara I,
Matsuoka H, Kawamura K (1997). Renal
angiosarcoma: a case report. Int J Urol 4:
90-93.
1097. Hirose M, Arakawa K, Kikuchi M,
Kawasaki T, Omoto T (1974). Primary reninism
with renal hamartomatous alteration.
JAMA 230: 1288-1292.
1098. Hockley NM, Bihrle R, Bennett
RM3rd, Curry JM (1989). Congenital genitourinary
hemangiomas in a patient with
the Klippel-Trenaunay syndrome: management
with the neodymium:YAG laser. J Urol
141: 940-941.
1099. Hodge KK, McNeal JE, Terris MK,
Stamey TA (1989). Random systematic versus
directed ultrasound guided transrectal
core biopsies of the prostate. J Urol 142: 71-
74.
1100. Hofmann MC, Jeltsch W, Brecher J,
Walt H (1989). Alkaline phosphatase
isozymes in human testicular germ cell
tumors, their precancerous stage, and
three related cell lines. Cancer Res 49:
4696-4700.
1101. Hoglund M, Sall T, Heim S, Mitelman
F, Mandahl N, Fadl-Elmula I (2001).
Identification of cytogenetic subgroups
and karyotypic pathways in transitional cell
carcinoma. Cancer Res 61: 8241-8246.
1102. Holck S, Jorgensen L (1983).
Verrucous carcinoma of urinary bladder.
Urology 22: 435-437.
1103. Holm-Nielsen P, Sorensen FB (1988).
Renal angiomyolipoma: an ultrastructural
investigation of three cases with histogenetic
considerations. APMIS Suppl 4: 37-47.
1104. Holmang S, Andius P, Hedelin H,
Wester K, Busch C, Johansson SL (2001).
Stage progression in Ta papillary urothelial
tumors: relationship to grade, immunohistochemical
expression of tumor markers,
mitotic frequency and DNA ploidy. J Urol
165: 1124-1128.
1105. Holmang S, Borghede G, Johansson
SL (1995). Primary small cell carcinoma of
the bladder: a report of 25 cases. J Urol 153:
1820-1822.
1106. Holmang S, Borghede G, Johansson
SL (1998). Bladder carcinoma with lymphoepithelioma-like
differentiation: a report
of 9 cases. J Urol 159: 779-782.
1107. Holmang S, Hedelin H, Anderstrom C,
Holmberg E, Busch C, Johansson SL (1999).
Recurrence and progression in low grade
papillary urothelial tumors. J Urol 162: 702-
707.
1108. Holmang S, Hedelin H, Anderstrom C,
Holmberg E, Johansson SL (2000).
Prospective registration of all patients in a
geographical region with newly diagnosed
bladder carcinomas during a two-year
period. Scand J Urol Nephrol 34: 95-101.
1109. Holmang S, Johansson SL (2001). The
nested variant of transitional cell carcinoma—a
rare neoplasm with poor prognosis.
Scand J Urol Nephrol 35: 102-105.
1110. Holmang S, Johansson SL (2002).
Stage Ta-T1 bladder cancer: the relationship
between findings at first followup cystoscopy
and subsequent recurrence and
progression. J Urol 167: 1634-1637.
1111. Holmes EJ (1977). Crystalloids of
prostatic carcinoma: relationship to
Bence-Jones crystals. Cancer 39: 2073-
2080.
1112. Holtl W, Hruby W, Redtenbacher M
(1982). Cavernous hemangioma originating
from prostatic plexus. Urology 20: 184-
185.
1113. Holzmann K, Blin N, Welter C, Zang
KD, Seitz G, Henn W (1993). Telomeric
associations and loss of telomeric DNA
repeats in renal tumors. Genes
Chromosomes Cancer 6: 178-181.
1114. Honda A, Shima M, Onoe S, Hanada
M, Nagai T, Nakajima S, Okada S (2000).
Botryoid Wilms tumor: case report and
review of literature. Pediatr Nephrol 14:
59-61.
1115. Honma K (1994). Paraganglia of the
urinary bladder. An autopsy study.
Zentralbl Pathol 139: 465-469.
1116. Hooper JD, Nicol DL, Dickinson JL,
Eyre HJ, Scarman AL, Normyle JF,
Stuttgen MA, Douglas ML, Loveland KA,
Sutherland GR, Antalis TM (1999). Testisin,
a new human serine proteinase
expressed by premeiotic testicular germ
cells and lost in testicular germ cell
tumors. Cancer Res 59: 3199-3205.
1117. Hopenhayn-Rich C, Biggs ML, Fuchs
A, Bergoglio R, Tello EE, Nicolli H, Smith
AH (1996). Bladder cancer mortality associated
with arsenic in drinking water in
Argentina. Epidemiology 7: 117-124.
1118. Hopkins SC, Nag SK, Soloway MS
(1984). Primary carcinoma of male urethra.
Urology 23: 128-133.
1119. Hopman AH, Kamps MA, Speel EJ,
Schapers RF, Sauter G, Ramaekers FC
(2002). Identification of chromosome 9
alterations and p53 accumulation in isolated
carcinoma in situ of the urinary bladder
versus carcinoma in situ associated with
carcinoma. Am J Pathol 161: 1119-1125.
1120. Hopman AH, Poddighe PJ, Smeets
AW, Moesker O, Beck JL, Vooijs GP,
Ramaekers FC (1989). Detection of numerical
chromosome aberrations in bladder
cancer by in situ hybridization. Am J
Pathol 135: 1105-1117.
1121. Horenblas S, van Tinteren H (1994).
Squamous cell carcinoma of the penis. IV.
Prognostic factors of survival: analysis of
tumor, nodes and metastasis classification
system. J Urol 151: 1239-1243.
1122. Hori K, Uematsu K, Yasoshima H,
Sakurai K, Yamada A (1997). Contribution
of cell proliferative activity to malignancy
potential in testicular seminoma. Pathol
Int 47: 282-287.
1123. Hori K, Uematsu K, Yasoshima H,
Yamada A, Sakurai K, Ohya M (1997).
Testicular seminoma with human chorionic
gonadotropin production. Pathol Int 47:
592-599.
1124. Hornak M, Pauer M, Bardos AJr,
Ondrus D (1987). The incidence of carcinoma
in situ in postpubertal undescended
testis. Int Urol Nephrol 19: 321-325.
1125. Horoszewicz JS, Kawinski E, Murphy
GP (1987). Monoclonal antibodies to a new
antigenic marker in epithelial prostatic
cells and serum of prostatic cancer
patients. Anticancer Res 7: 927-935.
1126. Horstman WG, Melson GL,
Middleton WD, Andriole GL (1992).
Testicular tumors: findings with color
Doppler US. Radiology 185: 733-737.
1127. Hosking DH, Bowman DM, McMorris
SL, Ramsey EW (1981). Primary carcinoid
of the testis with metastases. J Urol 125:
255-256.
1128. Houldsworth J, Reuter V, Bosl GJ,
Chaganti RS (1997). Aberrant expression
of cyclin D2 is an early event in human
male germ cell tumorigenesis. Cell
Growth Differ 8: 293-299.
1129. Houldsworth J, Xiao H, Murty VV,
Chen W, Ray B, Reuter VE, Bosl GJ,
Chaganti RS (1998). Human male germ cell
tumor resistance to cisplatin is linked to
TP53 gene mutation. Oncogene 16: 2345-
2349.
1130. Hsing AW, Tsao L, Devesa SS (2000).
International trends and patterns of
prostate cancer incidence and mortality.
Int J Cancer 85: 60-67.
1131. Hsueh C, Gonzalez-Crussi F, Murphy
SB (1993). Testicular angiocentric lymphoma
of postthymic T-cell type in a child
with T-cell acute lymphoblastic leukemia
in remission. Cancer 72: 1801-1805.
1132. Hsueh SF, Lai MT, Yang CC, Chung
YC, Hsu CP, Peng CC, Fu HH, Cheng YM,
Chang KJ, Yang SD (2002). Association of
overexpressed proline-directed protein
kinase F(A) with chemoresistance, invasion,
and recurrence in patients with
bladder carcinoma. Cancer 95: 775-783.
1133. Hu JC, Palapattu GS, Kattan MW,
Scardino PT, Wheeler TM (1998). The
association of selected pathological features
with prostate cancer in a singleneedle
biopsy accession. Hum Pathol 29:
1536-1538.
1134. Hu LM, Phillipson J, Barsky SH
(1992). Intratubular germ cell neoplasia in
infantile yolk sac tumor. Verification by
tandem repeat sequence in situ hybridization.
Diagn Mol Pathol 1: 118-128.
1135. Huang CH, Chen L, Hsieh HH (1992).
Choriocarcinoma presenting as a unilateral
renal mass and gross hematuria in a
male: report of a case. J Formos Med
Assoc 91: 922-925.
1136. Huang DJ, Stanisic TH, Hansen KK
(1992). Epithelioid sarcoma of the penis. J
Urol 147: 1370-1372.
1137. Huben RP, Mounzer AM, Murphy GP
(1988). Tumor grade and stage as prognostic
variables in upper tract urothelial
tumors. Cancer 62: 2016-2020.
1138. Huddart RA, Rajan B, Law M, Meyer
L, Dearnaley DP (1997). Spinal cord compression
in prostate cancer: treatment
outcome and prognostic factors.
Radiother Oncol 44: 229-236.
1139. Hudson DL, Guy AT, Fry P, O’Hare
MJ, Watt FM, Masters JR (2001).
Epithelial cell differentiation pathways in
the human prostate: identification of
intermediate phenotypes by keratin
expression. J Histochem Cytochem 49:
271-278.
1140. Huff V, Amos CI, Douglass EC, Fisher
R, Geiser CF, Krill CE, Li FP, Strong LC,
McDonald JM (1997). Evidence for genetic
heterogeneity in familial Wilms’ tumor.
Cancer Res 57: 1859-1862.
1141. Huff V, Compton DA, Chao LY, Strong
LC, Geiser CF, Saunders GF (1988). Lack of
linkage of familial Wilms’ tumour to chromosomal
band 11p13. Nature 336: 377-378.
1142. Huff V, Reeve AE, Leppert M, Strong
LC, Douglass EC, Geiser CF, Li FP,
Meadows A, Callen DF, Lenoir G,
Saunders GF (1992). Nonlinkage of 16q
markers to familial predisposition to
Wilms’ tumor. Cancer Res 52: 6117-6120.
1143. Hughson MD, Buchwald D, Fox M
(1986). Renal neoplasia and acquired cystic
kidney disease in patients receiving
long-term dialysis. Arch Pathol Lab Med
110: 592-601.
1144. Hull GW, Rabbani F, Abbas F, Wheeler
TM, Kattan MW, Scardino PT (2002). Cancer
control with radical prostatectomy alone in
1,000 consecutive patients. J Urol 167: 528-
534.
1145. Hull GW3rd, Genega EM, Sogani PC
(1999). Intravascular capillary hemangioma
presenting as a solid renal mass. J Urol 162:
784-785.
1146. Humphrey PA, Kaleem Z, Swanson PE,
Vollmer RT (1998). Pseudohyperplastic prostatic
adenocarcinoma. Am J Surg Pathol
22: 1239-1246.
1147. Humphrey PA, Vollmer RT (1990).
Intraglandular tumor extent and prognosis in
prostatic carcinoma: application of a grid
method to prostatectomy specimens. Hum
Pathol 21: 799-804.
1148. Huser J, Grignon DJ, Ro JY, Ayala AG,
Shannon RL, Papadopoulos NJ (1990). Adult
Wilms’ tumor: a clinicopathologic study of 11
cases. Mod Pathol 3: 321-326.
1149. Hussong J, Crussi FG, Chou PM (1997).
Gonadoblastoma: immunohistochemical
localization of Mullerian-inhibiting substance,
inhibin, WT-1, and p53. Mod Pathol
10: 1101-1105.
1150. IARC (1987). IARC Monographs on the
Evaluation of Carcinogenic Risks to Humans.
Overall evaluations of carcinogenicity: an
updating of IARC Monographs volumes 1 to
42. IARC Press: Lyon.
1151. IARC (1991). IARC Monographs on the
Evaluation of Carcinogenic Risks to Humans.
Coffee, tea, mate, methylxanthines and
methylglyoxal. IARC Press: Lyon.
1152. IARC (1994). IARC Monographs on the
Evaluation of Carcinogenic Risks to Humans.
Schistosomes, Liver Flukes, and
Helicobacter Pylori. IARC Press: Lyon.
1153. IARC (1995). IARC Monographs on the
Evaluation of Carcinogenic Risks to Humans.
Human papillomaviruses. IARC Press: Lyon.
1154. IARC (1999). IARC Monographs on the
Evaluation of Carcinogenic Risks to Humans.
Hormonal contraception and postmenopausal
hormonal therapy. IARC Press:
Lyon.
1155. IARC (1999). IARC Monographs on the
Evaluation of Carcinogenic Risks to Humans.
Some chemicals that cause tumours of the
kidney or urinary bladder in rodents, and
some other substances. IARC Press: Lyon.
1156. IARC (2002). IARC Handbooks of
Cancer Prevention. Weight control and
physical activity. IARC Press: Lyon.
1157. IARC (2004). IARC Monographs on the
Evaluation of Carcinogenic Risks to Humans.
Some Drinking-water Disinfectants and
Contaminants, including Arsenic. IARC
Press: Lyon (in press).
1158. IARC (2004). IARC Monographs on the
Evaluation of Carcinogenic Risks to Humans.
Tobacco smoke and involuntary smoking.
IARC Press: Lyon (in press).
1159. Iczkowski KA, Bostwick DG, Roche PC,
Cheville JC (1998). Inhibin A is a sensitive
and specific marker for testicular sex cordstromal
tumors. Mod Pathol 11: 774-779.
1160. Iczkowski KA, Ferguson KL, Grier DD,
Hossain D, Banerjee SS, McNeal JE,
Bostwick DG (2003). Adenoid cystic/basal
cell carcinoma of the prostate: clinicopathologic
findings in 19 cases. Am J Surg Pathol
27: 1523-1529.
1161. Iczkowski KA, Shanks JH, Gadaleanu
V, Cheng L, Jones EC, Neumann R,
Nascimento AG, Bostwick DG (2001).
Inflammatory pseudotumor and sarcoma of
urinary bladder: differential diagnosis and
outcome in thirty-eight spindle cell neoplasms.
Mod Pathol 14: 1043-1051.
References 323